STAGE III COLON CANCER AJCC V8

This large study is testing if adding a drug called atezolizumab, which helps the body's immune system fight cancer, to standard chemotherapy works better than chemotherapy alone. It's for patients with stage III colon cancer that has been surgically removed but has a high risk o…

This study is for people with a specific type of stage II or III colon cancer who have already had surgery and chemotherapy. It tests whether adding a new, targeted two-drug treatment after the standard care is better at keeping the cancer from coming back, compared to just watch…

This early-stage trial is testing whether combining existing cancer drugs with a new experimental drug (LY3214996) can help control advanced colorectal cancer that has stopped responding to standard treatments. The study aims to find safe doses and see if these combinations can s…

This study is testing a new two-drug combination for people with advanced colorectal cancer that has spread and is no longer responding to standard chemotherapy. The trial combines an experimental pill called SX-682, which aims to block tumor growth, with an existing immunotherap…

This study is for people with advanced colorectal cancer that has spread or cannot be removed by surgery and has a specific BRAF gene mutation. It tests if adding the immunotherapy drug nivolumab to two standard targeted drugs works better to control the cancer and stop it from g…

This study aims to understand the financial burden experienced by patients undergoing treatment for early-stage colon or rectal cancer. Researchers are following 565 patients for two years, asking them to complete surveys about treatment costs, employment changes, and quality of …